RITUXIMAB-PVVR

0 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking RITUXIMAB-PVVR:

# Side effect Count
See all common reactions for RITUXIMAB-PVVR

RITUXIMAB-PVVR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
See all enriched reactions for RITUXIMAB-PVVR